Prevalence of atopy in children with chronic constipation

D Simeone1, E Miele, G Boccia

  • 1National Health Service, Pietrelcina (BN) and Trentola Ducenta (CE), Italy.

Insights

This study found chronic constipation (CC) prevalence in children is 1.8%, with no increased atopy association. A cow's milk protein (CMP) elimination diet did not improve refractory constipation.

Area of Science:

  • Pediatrics
  • Gastroenterology
  • Allergy & Immunology

Background:

  • Chronic constipation (CC) is a common pediatric issue.
  • Atopy, a predisposition to allergic diseases, is prevalent in childhood.
  • The role of cow's milk protein (CMP) in pediatric constipation is debated.

Purpose of the Study:

  • To determine the prevalence of CC in a general pediatric population.
  • To investigate the association between CC and atopy in children.
  • To assess the efficacy of a CMP elimination diet for refractory CC.

Main Methods:

  • A 3-month cross-sectional study of 5113 children (0-12 years) for CC prevalence.
  • Evaluation of atopy in 69 constipated children (6 months-6 years) and matched controls using questionnaires and allergy testing.
  • A 4-week CMP elimination diet trial for 11 children with refractory CC.

Main Results:

  • CC prevalence was 1.8% in the overall study population.
  • Atopy prevalence in constipated children (17.3%) was similar to controls (18.8%).
  • No improvement in refractory CC was observed after a 4-week CMP elimination diet.

Conclusions:

  • Atopy prevalence is not higher in children with CC compared to the general population.
  • Cow's milk protein allergy does not appear to be a significant factor in refractory pediatric constipation.
Abstract

Related Concept Videos

Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...